Neuland Laboratories Limited
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.
What Neuland files
- Others73
- Investor Meet46
- Important30
- Updates16
- Board Meeting8
- PPTs8
Neuland Labs has confirmed July 24, 2026, as the record date. Shareholders holding shares on this date will be eligible for a final dividend of ₹34 per equity share for FY26. This payout reflects the company's strong performance, with the dividend expected to be disbursed shortly after shareholder approval at...
Neuland Labs' board proposes a final dividend of ₹34 per equity share for FY2025-26, boosting shareholder returns. The record date for eligible shareholders is July 24, 2026, with payment anticipated within five days of shareholder approval at the August 4, 2026 Annual General Meeting. Separately, the company plans a Unit...
Neuland Laboratories has announced a board meeting to approve the financial results for the quarter and half-year, proposing a final dividend of Rs. 12 per share for FY 2024-25. The record date for dividend entitlement is July 18, 2025. The 41st AGM is scheduled for July 30, 2025. Shareholders will...
Neuland Laboratories has announced a board meeting on the financial results for the quarter and half-year. The company reported a standalone profit of ₹259.43 Cr and consolidated profit of ₹260.11 Cr for FY 2024-25, with earnings per share around ₹202. The Board plans a final dividend of ₹12 per equity...